Atlas Trials

Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects

Clinical trial NCT01953367 · COMPLETED

Trial details

NCT number
NCT01953367
Sponsor
Pari Pharma GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2013-09-01
Primary completion
2013-11-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.